Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: KLAC stock price vs EVH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EVH's multiple
Needs EVH P/E.
Implied fair value · at KLAC's multiple
Needs EPS (TTM) is negative, KLAC P/E.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: KLAC FY 2026 (ended Jun 30, 2026) · EVH FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
KLA CORP · implied price per share
Bear
$35.17
Base
$41.37
Bull
$47.58
Evolent Health, Inc. · implied price per share
Bear
-$38.04
Base
-$44.75
Bull
-$51.46
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.05x
2.75x
Net debt / EBITDA
Leverage against operating earnings
0.53x
-2.89x
Cash and equivalents
Liquid reserves on the balance sheet
$3.13B
$196.20M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Applied Materials, Inc.
KLAC vs AMAT
LAM RESEARCH CORP
KLAC vs LRCX
TERADYNE, INC
KLAC vs TER
ASML HOLDING NV
KLAC vs ASML
Cigna Group
KLAC vs CI
MOLINA HEALTHCARE, INC.
KLAC vs MOH
Teladoc Health, Inc.
KLAC vs TDOC
CLOVER HEALTH INVESTMENTS, CORP. /DE
KLAC vs CLOV
UNITEDHEALTH GROUP INC
KLAC vs UNH
$6.64B
$1.14B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
